Company Overview
About Examedi
Examedi is a Santiago, Chile-based digital healthcare marketplace — backed by Y Combinator with $14.9 million in revenue in 2024, having received an M&A offer in April 2025 — connecting patients across Latin America with on-demand healthcare services including lab testing at home, telemedicine consultations, home nursing visits, and specialist appointments through a marketplace model that coordinates healthcare workers, labs, and facilities. Founded in 2021 by Andres Kemeny and Juan Pablo Zepeda, Examedi serves patients, employers, health plans, and healthcare facilities throughout Chile, Mexico, Colombia, and broader Latin America as a healthcare access intermediary.
Business Model & Competitive Advantage
Examedi's platform addresses Latin America's fragmented healthcare access problem: in most LatAm cities, patients navigate between public hospital systems (long waits, limited access), private clinics (expensive, disconnected), and independent lab facilities to obtain the full care pathway — a specialist referral, lab testing, imaging, and follow-up. Examedi's marketplace aggregates these touchpoints: patients book home lab visits (a phlebotomist comes to draw blood and process samples at a local lab), telemedicine consultations for common conditions, and in-person specialist appointments with same-day or next-day availability, creating a unified care coordination experience. The employer health benefit integration (corporate wellness plans that include Examedi access) provides B2B channel growth alongside B2C.
Competitive Landscape 2025–2026
In 2025, Examedi competes in the Latin American health tech marketplace market with DoctorAhora (telemedicine, Chile/LatAm), Doctolib (Europe-origin, LatAm expansion), and Sami (Brazil health plan, YC), and Doctor en Casa (home medical visit, Chile) for healthcare access intermediary positioning. LatAm healthcare technology has attracted significant venture investment as growing middle classes demand private healthcare access at more accessible prices than existing private clinic networks provide. The April 2025 M&A offer signals strategic interest from health plans, pharmacy chains, or regional healthcare consolidators seeking digital distribution capability. Y Combinator's backing positioned Examedi in the global health tech investment community. The 2025 strategy focuses on enterprise health benefit contracts (B2B employer channels), expanding telemedicine to the chronic condition management use case, and building the laboratory results intelligence layer.
Key Differentiators
Emerging Innovator
Examedi is an emerging player bringing innovative solutions to the Healthcare market.
Frequently Asked Questions
Estimated Visibility Trend (Beta)
Simulated 8-week rolling score
Based on estimated brand signals. Historical tracking coming soon.
Similar Brands
Epic Systems
Epic Systems Corporation was founded in 1979 by Judith Faulkner and is headquartered in Verona, Wisconsin, remaining privately held with Faulkner as majority owner. The company develops large-scale el
athenahealth
athenahealth is a cloud-based electronic health records (EHR), medical billing, and practice management company founded in 1997 and headquartered in Watertown, Massachusetts. The company was built on
Oracle Health
Oracle Health is the healthcare technology business unit of Oracle Corporation (NYSE: ORCL) — providing electronic health records (EHR), clinical workflow management, health information exchange, reve
Pfizer
Pfizer is one of the world's largest biopharmaceutical companies, founded in 1849 by cousins Charles Pfizer and Charles Erhart in Brooklyn, New York, and now headquartered in New York City. The compan
Moderna
Moderna is a clinical-stage biotechnology company that pioneered the development of messenger RNA (mRNA) therapeutics and vaccines, founded in 2010 by Noubar Afeyan, Robert Langer, Kenneth Chien, Stép
Amgen
Amgen Inc. is one of the world's largest biotechnology companies, headquartered in Thousand Oaks, California. Founded in 1980 as Applied Molecular Genetics, Amgen pioneered the development of biologic
Compare Examedi with Competitors
Side-by-side AI visibility scores, platform breakdown, and market position.
Claim This Profile
Are you from Examedi? Claim your profile to see full AI mention excerpts, get weekly visibility change alerts, and optimize how AI systems describe your brand.
Claim Examedi Profile →Track AI Visibility in Real Time
Monitor how ChatGPT, Gemini, Perplexity, and Claude mention Examedi vs competitors. Get alerts when AI recommendations shift.
Start Free Tracking →